Current accomplishments and targeted goals have CBSC well-positioned for significant growth in 2021 ESCONDIDO, CA / ACCESSWIRE / February 18, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), is pleased to provide an update on the progress and achievements we have made since transitioning to the Ambulatory Remote Cardiac Monitoring market in June of 2020. While we have faced, like so many others,...
Read more
CTCS HARVESTED BY PARSORTIX UNCOVER NOVEL METASTATIC BIOMARKER Parsortix system able to harvest difficult-to-detect mesenchymal CTCs Metastatic biomarker Cyr61 found by researchers in 40% of breast cancer CTCs may be a novel therapeutic target in treating drug-resistant breast cancers GUILDFORD, SURREY / ACCESSWIRE / February 18, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that...
Read more
SAN DIEGO, CA / ACCESSWIRE / February 17, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech" or the "Company"), a clinical-stage biotech company pioneering the development of monoclonal antibodies targeting treatment of various cancers and viral infections, is excited to announce the publication of strong In-Vitro study results from its research collaboration with Syracuse University. The data show that...
Read more
VANCOUVER, BC / ACCESSWIRE / February 17, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), announces the departure of Ms. Barinder Rasode as President and as a director of the Company, effective immediately. The Company also announces that its Chief Executive Officer, Mr. Tim Moore, has been appointed as a director of the Company. Ms. Rasode commented, "We created...
Read more
COLLEGE STATION, TX / ACCESSWIRE / February 16, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (the "Company") announced today the results of an in vitro study of the Company's ITV-1/IPF peptide treatment that demonstrated the broad efficacy with low toxicity. The Company's ITV-1 peptide was tested against human corona virus 229E Strain (HCoV-229E) and exhibited comparable efficacy but with a 20-fold lower toxicity than the widely...
Read more
RICHMOND HILL, ON / ACCESSWIRE / February 16, 2021 / Helix BioPharma Corp. (TSX:HBP), ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced the appointment of Dr. Frank Gary Renshaw to the Company's Scientific Advisory Board. Dr. Renshaw is a healthcare industry...
Read more
PJSC Pharmsynthez is leveraging Xenetic's PolyXen® technology to improve the pharmacological properties of its Epolong product candidate pursuant to a royalty-bearing collaboration agreement Russian registration filing of Epolong, a polysialylated form of recombinant human erythropoietin, follows previously reported positive Phase 3 data for the treatment of anemia in patients with chronic kidney disease FRAMINGHAM, MA /...
Read more
TORONTO, ON / ACCESSWIRE / February 16, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial results for the three months ended December 31, 2020 and provided an update on its business. Earlier this month, the company announced that it has been awarded a C$14 million reimbursement grant from the Canadian government. The funds will...
Read more
JUPITER, FL / ACCESSWIRE / February 15, 2021 / Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company's management will be...
Read more
MUNICH, GERMANY / ACCESSWIRE / February 15, 2021 / The fifteenth annual BIO-Europe Spring(R) conference, the premier springtime partnering conference for the life science industry, again is delivered fully digital for its 2021 edition. With an expanded format to four 24-hour days the event will accommodate partnering meetings between attendees from all over the world. BIO-Europe Spring is produced by EBD Group, the leading partnering firm for...
Read more
TUCSON, AZ / ACCESSWIRE / February 11, 2021 / Several recent publications have now highlighted the involvement of extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in the pathobiology of SARS-CoV-2 infection. In a comprehensive report published in the high impact journal CELL, of over 5,000 proteins identified as perturbed in COVID-19 patients who did not survive their illness compared to controls, NAMPT expression was linked to...
Read more
Capital Raise to Fund VenoValve U.S. Pivotal Trial IRVINE, CA / ACCESSWIRE / February 11, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has successfully completed a public offering of its securities generating approximately $41.4 million of gross proceeds, prior to deducting underwriting discounts and commissions, and expenses. The...
Read more
NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company developing next generation treatments for unmet neuronal diseases, using tissue engineering, stem cells and machine learning synergic technologies is proud to announce the launch of its newly redesigned web site at https://www.qrons.com The new site reflects Qrons' focus on extending its proprietary traumatic brain injury...
Read more
Hypertension program evaluating effectiveness of DehydraTECH-processed CBD now consists of three human clinical studies and two animal studies KELOWNA, BC / ACCESSWIRE / February 11, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces significant progress in its 2021 applied research and development (R&D)...
Read more
Companies to form a strategic partnership to collaborate on new monitoring solutions for growing international remote cardiac monitoring markets SHENZHEN, CHINA and ESCONDIDO, CA / ACCESSWIRE / February 11, 2021 / CB Scientific. Inc. (OTC PINK:CBSC)("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, is pleased to announce that it has entered...
Read more
MainPointe Pharmaceuticals Completes Initial Share Purchase per Investment Agreement VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, announced today it has closed the first tranche of the investment by MainPointe Pharmaceuticals...
Read more
CAPE TOWN, SA / ACCESSWIRE / February 9, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update regarding its MedspressoTm brand focused on creating premium African functional beverages: This past week MedspressoTm set the seal on its alliance with South African...
Read more
IRVINE, CA / ACCESSWIRE / February 9, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of its upsized underwritten public offering of units for gross proceeds of approximately $36 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the company. The public offering is comprised of 5,142,856...
Read more
CARLSBAD, CA / ACCESSWIRE / February 9, 2021 / OPTEC International, Inc. (OTC PINK:OPTI), a developer of UV and UV-C safety products using related advanced technologies specific to Personal Protection Equipment (PPE), today announced the addition of Antigen & Antibody Rapid-Test Kits with highly accurate results in 10 Minutes to the company's PPE Inventory for global distribution. The Rapid-Test Kits are manufactured in the USA and...
Read more
Developed with NASA as a patented pathogen killing technology Proprietary photocatalytic oxidation process thoroughly destroys viruses, bacteria, spores, and fungi as well as other carbon-based molecules Airocide® air disinfection technology compliments and expands the SteriLumen platform, together providing a more comprehensive solution for air and surface Accelerates the strategy to grow revenues through complimentary...
Read more
